We introduced Apc mutation into wild-type (WT) small intestinal organoids by CRISPR-Cas9 and we selected Apc-mutant organoids, representing the adenoma stage of intestinal tumors, without adding the external Wnt-agonist R-Spondin1. Here, APC is linked to adenoma.